PMID,Title,Journal,Year
40652432,Impact of SGLT2i on bone health in patients with lupus nephritis: randomized double blinded placebo-controlled clinical trial.,Journal of nephrology,2025
39835073,The Role of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Treating Lupus Nephritis: A Systematic Review.,Cureus,2024
39401147,Dapagliflozin for rheumatic musculoskeletal disease in patients with chronic kidney disease.,Modern rheumatology,2025
37093522,Lupus Nephritis: New and Emerging Biologic and Targeted Therapies.,"BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy",2023
36415370,Septic Shock Due to Urinary Tract Infection in an Immunosuppressed Patient Prescribed Dapagliflozin.,Cureus,2022
36288823,Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: a phase I/II trial.,RMD open,2022
